Indeed, opinions differ on whether positivity should be assessed only for tumour cells or additionally for immune infiltrating cells.33 An automated process to quantifying cell patterns promotes consistency and reproducibility and could facilitate its use to support the role of PD-L1 in personalised treatment strategies. The gene discussed is CD274; the disease is neoplasm.